Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17061428 | 0.96 | TDP1 (0.44) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL13052708 | 0.92 | TDP1 (0.41) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL14181196 | 0.92 | TDP1 (0.41) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL9763744 | 0.88 | TDP1 (0.41) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL15356580 | 0.88 | POLB (0.38) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL18216802 | 0.88 | POLB (0.38) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL9764044 | 0.87 | TDP1 (0.45) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL17061426 | 0.86 | TDP1 (0.44) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL2367678 | 0.86 | TDP1 (0.44) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL1398279 | 0.86 | TDP1 (0.44) | TDP1POLBAPEX1HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203225-A1 | COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT EMITTING ELEMENT AND ORGANIC LIGHT EMITTING ELEMENT DISPLAY DEVICE MANUFACTURED THEREFROM | SAMSUNG SDI CO LTD (KR) | 2023-06-29 | — | — | US | disclosed |
| US-20230203225-A1 | COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT EMITTING ELEMENT AND ORGANIC LIGHT EMITTING ELEMENT DISPLAY DEVICE MANUFACTURED THEREFROM | SAMSUNG SDI CO LTD (KR) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203225-A1 | COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT EMITTING ELEMENT AND ORGANIC LIGHT EMITTING ELEMENT DISPLAY DEVICE MANUFACTURED THEREFROM | ORMDL3, NOTUM, WEE1 | TDP1 2787/4885POLB 3654/4885APEX1 3137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.